Cargando…

Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment

Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Litwin, Tomasz, Dusek, Petr, Szafrański, Tomasz, Dzieżyc, Karolina, Członkowska, Anna, Rybakowski, Janusz K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022881/ https://www.ncbi.nlm.nih.gov/pubmed/29977520 http://dx.doi.org/10.1177/2045125318759461

Ejemplares similares

Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson’s Disease Rating Scale
por: Członkowska, Anna, et al.
Publicado: (2018)

The sunflower cataract in Wilson’s disease: pathognomonic sign or rare finding?
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2015)

Optical coherence tomography as a marker of neurodegeneration in patients with Wilson’s disease
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2017)

Brain volume is related to neurological impairment and to copper overload in Wilson’s disease
por: Smolinski, Lukasz, et al.
Publicado: (2019)

Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Grażyna, Gromadzka, et al.
Publicado: (2013)

Erratum to: Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Gromadzka, Grażyna, et al.
Publicado: (2014)

MR image mimicking the “eye of the tiger” sign in Wilson’s disease
por: Litwin, T., et al.
Publicado: (2014)

Persistence with treatment for Wilson disease: a retrospective study
por: Masełbas, Wojciech, et al.
Publicado: (2019)

Concordance rates of Wilson’s disease phenotype among siblings
por: Chabik, Grzegorz, et al.
Publicado: (2013)

Social and demographic characteristics of a Polish cohort with Wilson disease and the impact of treatment persistence
por: Maselbas, Wojciech, et al.
Publicado: (2019)

Erratum to: Concordance rates of Wilson’s disease phenotype among siblings
por: Chabik, Grzegorz, et al.
Publicado: (2014)

Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson’s disease
por: Jernajczyk, Wojciech, et al.
Publicado: (2022)

Cardiac assessment in Wilson’s disease patients based on electrocardiography and echocardiography examination
por: Buksińska-Lisik, Małgorzata, et al.
Publicado: (2017)

Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
por: Medici, Valentina, et al.
Publicado: (2021)

Blink reflex in newly diagnosed and treated patients with Wilson’s disease
por: Bembenek, Jan P., et al.
Publicado: (2021)

Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson’s disease
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2015)

Influence of BDNF polymorphisms on Wilson’s disease susceptibility and clinical course
por: Mirowska-Guzel, Dagmara, et al.
Publicado: (2013)

Autoantibodies in Wilson disease: Impact on clinical course
por: Antczak‐Kowalska, Magdalena, et al.
Publicado: (2022)

Blood Based Biomarkers of Central Nervous System Involvement in Wilson’s Disease
por: Antos, Agnieszka, et al.
Publicado: (2023)

D-Penicillamine-Induced Myasthenia Gravis—A Probable Complication of Wilson’s Disease Treatment—A Case Report and Systematic Review of the Literature
por: Antos, Agnieszka, et al.
Publicado: (2023)

Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review
por: Litwin, Tomasz, et al.
Publicado: (2023)

Liver transplantation as a treatment for Wilson’s disease with neurological presentation: a systematic literature review
por: Litwin, Tomasz, et al.
Publicado: (2022)

Psychiatric manifestations of Wilson’s disease
por: Freitas, R. Mota, et al.
Publicado: (2021)

Evaluation of liver fibrosis in patients with Wilson’s disease
por: Przybyłkowski, Adam, et al.
Publicado: (2020)

Psychiatric manifestations of Wilson's disease and treatment with electroconvulsive therapy
por: Sahoo, Manoj Kumar, et al.
Publicado: (2010)

Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
por: Antos, Agnieszka, et al.
Publicado: (2023)

The Maternal and Fetal Outcomes of Pregnancy in Wilson’s Disease: A Systematic Literature Review and Meta-Analysis
por: Litwin, Tomasz, et al.
Publicado: (2022)

The effect of gender on brain MRI pathology in Wilson’s disease
por: Litwin, T., et al.
Publicado: (2013)

Intestinal expression of metal transporters in Wilson’s disease
por: Przybyłkowski, Adam, et al.
Publicado: (2013)

Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes
por: Mazi, Tagreed A., et al.
Publicado: (2019)

Electro Convulsive Therapy in Psychiatric Manifestations in Wilson's Disease
por: Vaishnav, Parth, et al.
Publicado: (2013)

A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment
por: Penning, Louis C., et al.
Publicado: (2023)

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

The Role of Zinc in the Treatment of Wilson’s Disease
por: Avan, Abolfazl, et al.
Publicado: (2022)

Screening of Wilson’s disease in a psychiatric population: difficulties and pitfalls. A preliminary study
por: Demily, Caroline, et al.
Publicado: (2017)

Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson’s disease
por: Gromadzka, Grażyna, et al.
Publicado: (2021)

Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers
por: Mordaunt, Charles E., et al.
Publicado: (2019)

120th Anniversary of the Kraepelinian Dichotomy of Psychiatric Disorders
por: Rybakowski, Janusz K.
Publicado: (2019)

Wilson′s disease Presenting with Neuropsychiatric Manifestations.
por: Jacob, Rajesh, et al.
Publicado: (2004)

Transcranial sonography changes in heterozygotic carriers of the ATP7B gene
por: Skowronska, Marta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_98nej6mqu28f1e6vu21rlsvvid